LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study

Z Yin, S Liu, X Yang, M Chen, J Du, H Liu, L Yang - Molecules, 2023 - mdpi.com
As one of the crucial targets of epigenetics, histone lysine-specific demethylase 1 (LSD1) is
significant in the occurrence and development of various tumors. Although several …

Identification of novel HIV 1-protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening

D Yadav, S Paliwal, R Yadav, M Pal, A Pandey - PloS one, 2012 - journals.plos.org
A combined ligand and structure-based drug design approach provides a synergistic
advantage over either methods performed individually. Present work bestows a good …

Identification of novel TRPC5 inhibitors by pharmacophore-based and structure-based approaches

S Li, S Zhang, D Chen, X Jiang, B Liu, H Zhang… - … Biology and Chemistry, 2020 - Elsevier
Canonical transient receptor potential-5 (TRPC5), which belongs to the subfamily of
transient receptor potential (TRP) channels, is a non-selective cation channel mainly …

Pharmacokinetic and molecular docking studies of natural plant compounds of Hibiscus sabdariffa to design antihypertensive compounds targeting AT2R

B Sharma - … Journal of Computational Biology and Drug …, 2021 - inderscienceonline.com
AT2R is one of the component of renin-angiotensin system (RAS) plays a role in mediating
anti-proliferation, vasodilatation, cellular differentiation, and apoptosis. In the present study …

In silico identification of novel lead compounds with AT1 receptor antagonist activity: successful application of chemical database screening protocol

M Pal, S Paliwal - Organic and medicinal chemistry letters, 2012 - Springer
Background AT 1 receptor antagonists are clinically effective drugs for the treatment of
hypertension, cardiovascular, and related disorders. In an attempt to identify new AT 1 …

Chemical Feature‐Based Molecular Modeling of Urotensin‐II Receptor Antagonists: Generation of Predictive Pharmacophore Model for Early Drug Discovery

A Pandey, SK Paliwal, SK Paliwal - Journal of Chemistry, 2014 - Wiley Online Library
For a series of 35 piperazino‐phthalimide and piperazino‐isoindolinone based urotensin‐II
receptor (UT) antagonists, a thoroughly validated 3D pharmacophore model has been …

Discovery of novel DPP IV inhibitors: application of pharmacophore-based virtual screening

J Sharma, D Yadav, S Paliwal - Medicinal Chemistry Research, 2013 - Springer
Abstract Dipeptidyl peptidase IV (DPP-IV) is a potential drug target for type-2 diabetes and
DPP-IV inhibitors are known to efficiently improve glucose tolerance. In the present study …

[PDF][PDF] Ligand and Structure-Based Pharmacophore Modelling, Computer-aided Screening and Molecular Docking to Detect Novel NS5B Polymerase Inhibitors as …

A Derashri, A Dwivedi, M Maan, DD Bhandari - 2022 - biointerfaceresearch.com
The ongoing interest of researchers in the direct-acting NS5B inhibitors in the development
of viral disease hepatitis has attracted our attention in the direction of the development of a …

In-Silico Screening of Ligand Based Pharmacophore, Database Mining and Molecular Docking on 2, 5-Diaminopyrimidines Azapurines as Potential Inhibitors of …

P Mishra, S Kesar, SK Paliwal… - … System Agents in …, 2018 - ingentaconnect.com
Background: Glycogen synthase kinase-3β plays a significant role in the regulation of
various pathological pathways relating to the Central Nervous System (CNS). Dysregulation …

[引用][C] The war against pain: the design, synthesis and testing of potential COX-2 selective inhibitors.

CA Slabber - 2014